Applications of Electron Transfer Initiated Cyclizations

电子转移引发环化的应用

基本信息

项目摘要

The purpose of this proposal is to continue the development of the electron transfer initiated cyclization reaction and to use this methodology for the synthesis of biologically important structures. In this reaction the photoinitiated single electron oxidation of alkylarenes substituted at the homobenzylic position with an electron donating substituent produces radical cations containing substantially weakened and polarized benzylic carbon-carbon bonds. Appended nucleophiles, such as hydroxyl, ether, and amide groups can displace benzylic radicals, resulting in a cyclization reaction. The mild reaction conditions and unique chemoselectivity exhibited by single electron transfer make this reaction a potentially very powerful new method for constructing organic molecules. Specific goals for the project include: A thorough study of the types of cation stabilizing substituents, aromatic leaving groups, and nucleophiles tolerated by this reaction. This study includes the development of new heterogenerative cascade reactions. The development of a chemically initiated variant of the reaction. The development of an electron transfer initiated cyclorelease reaction from a polymer support. Employment of the reaction as the key step in brief total syntheses of potent antitumor and immunosuppressant agents from the pederin and mycalamide family, and the use of these sequences in the synthesis of analogs. The proposed program provides both new methodology for organic synthesis and efficient routes to challenging and medicinally important structures.
这项建议的目的是继续发展电子转移引发的环化反应,并使用这种方法来合成具有生物重要性的结构。在该反应中,高苯基取代的烷基芳烃与给电子取代基光引发的单电子氧化反应生成含有大量弱化和极化的苄基碳-碳键的自由基阳离子。添加的亲核试剂,如羟基、乙醚和酰胺基团,可以取代苄基自由基,导致环化反应。反应条件温和,单电子转移显示出独特的化学选择性,使该反应成为一种潜在的非常有效的构建有机分子的新方法。该项目的具体目标包括:深入研究该反应所能容忍的阳离子稳定取代基、芳香族离开基团和亲核剂的类型。这项研究包括新的异源级联反应的开发。化学引发的反应的变种的发展。电子转移的发展引发了从聚合物载体上的环释放反应。将该反应作为从胡萝卜素和麦角酰胺家族合成高效抗肿瘤和免疫抑制剂的简要全合成的关键步骤,并将这些序列用于合成类似物。拟议的计划既为有机合成提供了新的方法,也为具有挑战性和医学重要性的结构提供了有效的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul E Floreancig其他文献

Paul E Floreancig的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul E Floreancig', 18)}}的其他基金

Design, Synthesis, and Evaluation of ant-Glioblastoma Agents
抗胶质母细胞瘤药物的设计、合成和评估
  • 批准号:
    10260581
  • 财政年份:
    2020
  • 资助金额:
    $ 23.73万
  • 项目类别:
Design, Synthesis, and Evaluation of ant-Glioblastoma Agents
抗胶质母细胞瘤药物的设计、合成和评估
  • 批准号:
    10439861
  • 财政年份:
    2020
  • 资助金额:
    $ 23.73万
  • 项目类别:
Design, Synthesis, and Evaluation of ant-Glioblastoma Agents
抗胶质母细胞瘤药物的设计、合成和评估
  • 批准号:
    10647664
  • 财政年份:
    2020
  • 资助金额:
    $ 23.73万
  • 项目类别:
Stereoselective Synthesis through Allylic Alcohol Transposition and Trapping
通过烯丙醇转位和捕获进行立体选择性合成
  • 批准号:
    9302465
  • 财政年份:
    2015
  • 资助金额:
    $ 23.73万
  • 项目类别:
Applications of Electron Transfer Initiated Cyclizations
电子转移引发环化的应用
  • 批准号:
    7692246
  • 财政年份:
    2002
  • 资助金额:
    $ 23.73万
  • 项目类别:
Applications of Electron Transfer Initiated Cyclizations
电子转移引发环化的应用
  • 批准号:
    6433832
  • 财政年份:
    2002
  • 资助金额:
    $ 23.73万
  • 项目类别:
Applications of Electron Transfer Initiated Cyclizations
电子转移引发环化的应用
  • 批准号:
    7098111
  • 财政年份:
    2002
  • 资助金额:
    $ 23.73万
  • 项目类别:
Applications of Electron Transfer Initiated Cyclizations
电子转移引发环化的应用
  • 批准号:
    6786686
  • 财政年份:
    2002
  • 资助金额:
    $ 23.73万
  • 项目类别:
Applications of Electron Transfer Initiated Cyclizations
电子转移引发环化的应用
  • 批准号:
    8117049
  • 财政年份:
    2002
  • 资助金额:
    $ 23.73万
  • 项目类别:
Applications of Electron Transfer Initiated Cyclizations
电子转移引发环化的应用
  • 批准号:
    6923595
  • 财政年份:
    2002
  • 资助金额:
    $ 23.73万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 23.73万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 23.73万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 23.73万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 23.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 23.73万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 23.73万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 23.73万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 23.73万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 23.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 23.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了